You are here
AusPAR: Secukinumab
Related information
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
3 February 2021
| AusPAR | |
|---|---|
| Active Ingredient | Secukinumab
|
| Product Name | Cosentyx
|
| Sponsor | Novartis Pharmaceuticals Australia Pty Ltd
|
| Submission Number | PM-2019-04601-1-3
|
| Submission Type | Extension of indications
|
| Decision | Approved
|
| AusPAR Date | 27 January 2021
|
| Publication Date | 3 February 2021 |